Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers.

Autor: Kristin Jonsdottir, Susanne R Janssen, Fabiana C Da Rosa, Einar Gudlaugsson, Ivar Skaland, Jan P A Baak, Emiel A M Janssen

Publikováno v: PLoS ONE, Vol 7, Iss 11, p e48692 (2012)

INTRODUCTION: Although lymph node negative (LN-) breast cancer patients have a good 10-years survival (∼85%), most of them still receive adjuvant therapy, while only some benefit from this. More accurate prognostication of LN- breast cancer patient

Externí odkaz: https://doaj.org/article/053cc98006904c24a168d27101ef819e

Real-world evidence on therapeutic strategies and treatment-sequencing in patients with chronic lymphocytic leukemia: an international study of ERIC, the European research initiative on CLL [Abstract]

Autor: Luana Schiattone, Michel van Gelder, Jana Zuchnická, Viola Maria Popov, Rosa Collado, Candida Vitale, Marta Coscia, Gloria Iacoboni, Marta Morawska, Amy Christian, Darko Antic, Vojin Vukovic, Jorge Labrador, Elżbieta Kalicińska, Marek Trněný, Anna Puiggros, Biljana Mihaljevic, Gian Matteo Rigolin, Ioannis Kotsianidis, Dimitra Chammou, Francesca Bacchiarri, Alberto Fresa, Niki Stavroyianni, Sara Galimberti, Alicia Enrico, Lydia Scarfò, David Donaldson, Jacopo Olivieri, Cheyenne Pierie, Irina Panovska, Tamar Tadmor, Maria Papaioannou, Kostas Stamatopoulos, Christos Demosthenous, Mohamed A. Yassin, Olga Kalashnikova, Fatih Demirkan, Yair Herishanu, Livio Trentin, Theodoros P. Vassilakopoulos, Volkan Karakuş, Alessandro Gozzetti, Almudena Navarro-Bailón, Maya Koren-Michowitz, Carlota Mayor-Bastida, Eric Tse, Šárka Pospíšilová, Lucrecia Yáñez, Georgios Karakatsoulis, Roberta Murru, Martin Spacek, Rocío García-Serra, Susanne R. Janssen, Robert J. Kreitman, Michael Doubek, Valerio Guarente, Eugene Nikitin, Uttam Kumar Nath, Anastasia Chatzidimitriou, Iliana Konstantinou, Arnon P. Kater, Ivana Milosevic, Annett Schiwitza, Martin Simkovic, Romain Guièze, Zhenshu Xu, Andrea Visentin, Stanislava Maslejova, Rosa Ruchlemer, Ömür Gökmen Sevindik, Gimena Dos Santos, Alberto Lopez-Garcia, Thomas Chatzikonstantinou, Francesc Bosch Albareda, Miguel Alcoceba, E. Minga, Eleftheria Hatzimichael, Elisa Albi, Lukas Smolej, Gianluca Gaidano, Rainer Claus, Antonio Cuneo, Kamel Laribi, Ramona Cassin, Michalis Iskas, Jana Kotašková, Panayiotis Panayiotidis, Tomas Papajik, Ozren Jakšić, Fatima Miras, Paolo Ghia, Maria Efstathopoulou, Luca Inchiappa, Bonnie Kho, Marcos Daniel De Deus Santos, Barbara Dreta, Constantine S. Tam, George Vrachiolias, Münci Yağcı, Blanca Espinet, B V Biderman, Stephen P. Mulligan, Zadie Davis, Svetlana Smirnova, David Oscier, Juan Marquet Palomanes, Liat Tourjeman, Sofia Chatzileontiadou, Maria Dimou, Riccardo Moia, Isabel González-Gascón y Marín, Anne Calleja, Kristina Tomic, Ilana Levy, Mehreen Ali Khan, Gerasimos Pangalis, Sean Harrop, Thérèse Aurran, Paolo Sportoletti, Dina Sameh Soliman, Shaimaa El-Ashwah, Maria K. Angelopoulou, Gianluigi Reda, Fatiha Merabet, Yandong Shen, Mark Catherwood, Luca Laurenti, Thomas Longval, Deepesh Lad

The use of novel small molecule inhibitors alone or in combination with anti-CD20 monoclonal antibodies for chronic lymphocytic leukemia (CLL) has raised a number of questions on efficacy, tolerability, long-term treatment adherence in patients with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7a9f4cccd98d74d74691a8db760f3b4
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/98560

IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization

Autor: Ayana L. Henderson, Ayush Pant, John N. Hutchinson, Ana Garcia Del Rio, Ann M. Gifford, Asaf Spiegel, Christine L. Chaffer, Susanne R Janssen, Sandra S. McAllister, Molly J. DeCristo, Anushka Dongre, Jessalyn M. Ubellacker, Tyler Laszewski, Beatriz P. San Juan, Robert A. Weinberg, Zafira Castaño, Ferenc Reinhardt, Zachary T. Herbert

Publikováno v: Nature cell biology. 20(9)

Lack of insight into mechanisms governing breast cancer metastasis has precluded the development of curative therapies. Metastasis-initiating cancer cells (MICs) are uniquely equipped to establish metastases, causing recurrence and therapeutic resist

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec70cdd9585bf9d4e50cc47c0587bc59
https://pubmed.ncbi.nlm.nih.gov/30154549

Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers

Autor: Einar Gudlaugsson, Jan P. A. Baak, Ivar Skaland, Fabiana C. Da Rosa, Susanne R. Janssen, Emiel A. M. Janssen, Kristin Jonsdottir

Publikováno v: PLoS ONE
Jonsdottir, K, Janssen, S R, Da Rosa, F C, Gudlaugsson, E, Skaland, I, Baak, J P A & Janssen, E A M 2012, ' Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers ', PLoS ONE, vol. 7, no. 11, e48692 . https://doi.org/10.1371/journal.pone.0048692
PLoS ONE, Vol 7, Iss 11, p e48692 (2012)
PLoS ONE, 7(11):e48692. Public Library of Science

INTRODUCTION: Although lymph node negative (LN-) breast cancer patients have a good 10-years survival (∼85%), most of them still receive adjuvant therapy, while only some benefit from this. More accurate prognostication of LN- breast cancer patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf7890806fa24b04016e1fec43394c20
https://doi.org/10.1371/journal.pone.0048692